Get access to our best features
Get access to our best features
Published

Ozempic and Mounjaro may also lower your risk of obesity-linked cancer

Summary by National Geographic
A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)